|4Mar 28, 4:40 PM ET

JORGENSEN DANIEL 4

4 · POLYMEDIX, INC · Filed Mar 28, 2012

Insider Transaction Report

Form 4
Period: 2012-03-26
JORGENSEN DANIEL
Sr VP Clin Dev/Chief Med Off
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-03-26+255,000255,000 total
    Exercise: $1.22Exp: 2022-03-25Common Stock (255,000 underlying)
Footnotes (1)
  • [F1]The options will vest monthly over a three-year period, beginning in the first month subsequent to the date of grant.

Documents

1 file
  • 4
    jorg4032812.xmlPrimary

    OWNERSHIP DOCUMENT